Motion text
That this House recognises hepatitis C is a leading cause of premature death from liver disease; acknowledges that the condition is curable in most cases; understands that there are inequalities in access to treatment and diagnosis for people in disadvantaged groups; notes that recent data has revealed that the UK is falling behind targets to meet its commitment to eliminating hepatitis C as a public health concern by 2030; further notes that the reduction in price of new HCV oral therapies puts the NHS in a position to work innovatively with industry to look at how it can find and treat more patients and faster; notes a recent article in the Lancet which states that domestic funding is unlikely to be able to deliver the results in the 13 years that remain till 2030; and calls on the NHS to bring forward the publication of an elimination strategy for the UK, which includes innovative, long-term activities with industry, stakeholders and community-based organisations across the health sector.
Signatures (11)
The first 6 Members who have signed to support the motion are the sponsors. The primary sponsor is generally the person who tabled the motion and has responsibility for it. The date shown is when the Member signed the motion.
Sharma, Mr Virendra
Labour
Signed on
14 November 2017
Shannon, Jim
Democratic Unionist Party
Signed on
15 November 2017
Blackman, Bob
Conservative
Signed on
15 November 2017
Stephens, Chris
Scottish National Party
Signed on
15 November 2017
Vaz, Keith
Labour
Signed on
16 November 2017
Hermon, Lady
Independent
Signed on
16 November 2017
In addition to the sponsors, the following Members have signed to support the motion.
There are no withdrawn signatures for this motion.